Charles Cherington - Jul 31, 2023 Form 4 Insider Report for Comera Life Sciences Holdings, Inc. (CMRA)

Role
10%+ Owner
Signature
/s/ Charles Cherington
Stock symbol
CMRA
Transactions as of
Jul 31, 2023
Transactions value $
$450,044
Form type
4
Date filed
8/25/2023, 07:33 PM
Previous filing
Aug 25, 2023
Next filing
Sep 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMRA Common Stock Purchase $450K +880K +30.57% $0.51 3.76M Jul 31, 2023 Direct F1
holding CMRA Common Stock 1.27M Jul 31, 2023 By LLC F2
holding CMRA Common Stock 95.3K Jul 31, 2023 By trust F3
holding CMRA Common Stock 95.3K Jul 31, 2023 By trust F4
holding CMRA Common Stock 95.3K Jul 31, 2023 By trust F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMRA Warrants to Purchase Common Stock Purchase $0 +2.2M $0.00 2.2M Jul 31, 2023 Common Stock 2.2M $0.61 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 31, 2023, pursuant to a private placement offering by the Issuer, the Reporting Person acquired 880,195 shares of the Issuer's Common Stock and Warrants to purchase up to 2,200,488 shares of Common Stock. The combined purchase price per share of Common Stock and accompanying Warrant in the offering was $0.51125, with all of the purchase price allocated to the shares of Common Stock.
F2 Held by Cherington Holdings LLC, of which the reporting person is a partner.
F3 Held by Ashley S. Pettus 2012 Irrevocable Trust FBO Benjamin P. Cherington, of which the reporting person is trustee.
F4 Held by Ashley S. Pettus 2012 Irrevocable Trust FBO Cyrus B. Cherington, of which the reporting person is trustee.
F5 Held by Ashley S. Pettus 2012 Irrevocable Trust FBO Henry S. Cherington, of which the reporting person is trustee.
F6 The exercisability of the Warrants is subject to a 19.99% beneficial ownership limitation.